Szymon Jarosławski

In eHealth in India today, the nature of work, the challenges and the finances: an interview-based study

Szymon Jarosławski, Gayatri Saberwal · BMC Medical Informatics and Decision Making · 2014 · 110 citations · Full text

Sipuleucel-T (Provenge®)—Autopsy of an Innovative Paradigm Change in Cancer Treatment: Why a Single-Product Biotech Company Failed to Capitalize on its Breakthrough Invention

Szymon Jarosławski, Mondher Toumi · BioDrugs · 2015 · 52 citations

Preclinical Therapeutics, Pharmaceutical Research, Innovative Paradigm Change +13

Case studies of innovative medical device companies from India: barriers and enablers to development

Szymon Jarosławski, Gayatri Saberwal · BMC Health Services Research · 2013 · 42 citations · Full text

The Use of Surrogate and Patient-Relevant Endpoints in Outcomes-Based Market Access Agreements

Mondher Toumi, Szymon Jarosławski, Toyohiro Sawada et al. · Applied Health Economics and Health Policy · 2016 · 23 citations

Health Policy, Clinical Endpoint, Health Care Reimbursement +8

Patient-reported outcome claims in European and United States orphan drug approvals

Szymon Jarosławski, Pascal Auquier, Borislav Borissov et al. · Journal of Market Access & Health Policy · 2018 · 22 citations · Full text